Refine by
7 results found
-
Q&A with NIMH Director Dr. Josh Gordon
NAMI asks NIMH director, Dr. Josh Gordon, about the future of mental illness research. -
NAMIWalks: Keeping Hope Alive
"It was a thrill to show up the morning of the walk, turning in the money I raised. I remember thinking that before my family needed NAMI, someone else took the time to walk and donate. Now it was my turn to raise money and walk for other families that unknowingly needed NAMI’s support." -
Taking Another Look a Too-Often-Forgotten Treatment for Schizophrenia
We don’t endorse specific treatments at NAMI, but in my role as medical director, I always like to remind people about clozapine. The consensus in the medical community is that, generally speaking, it is an underutilized treatment.
-
Leader of Landmark Gene Research on Schizophrenia to Speak at NAMI Convention
Dr. Steven McCarroll, who led the research team responsible for a study that examines the gene that may be a risk factor for schizophrenia, will speak at this year’s NAMI National Convention, July 6–9 in Denver. -
Shared Decision Making: Empowering People Living with Mental Illness
There isn't always enough time to discuss everything you want when you meet with your doctor. Pat Deegan explains how shared decision making can help. -
The Depression Boom: As US Population Ages, Mental Illness Rises
NAMI recently spoke with Dr. Dilip Jeste, a keynote speaker at the 2013 NAMI National Convention and an expert on mental illness in older populations. -
Can Combining Therapies Have a Synergistic Effect?
Researchers are testing to see if utilizing both cognitive adaption training (CAT) and cognitive behavioral therapy for psychosis (CBTP) at the same time produces even more salubrious results.